Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 65,645 shares at $74.08 ($4.9M) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Scheduled sale ($4.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.08 | 11,218 | $831K | 17.0% |
| 2 | $74.08 | 11,218 | $831K | 17.0% |
| 3 | $74.20 | 14,355 | $1.1M | 21.7% |
| 4 | $75.14 | 10,837 | $814K | 16.6% |
| 5 | $75.14 | 10,837 | $814K | 16.6% |
| 6 | $75.98 | 3,590 |
| $273K |
| 5.6% |
| 7 | $75.98 | 3,590 | $273K | 5.6% |
| Total | $74.66 avg | 65,645 | $4.9M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-10-03 | $6.8M | — | Filing → |